What barriers and enablers do primary care clinicians perceive when implementing cardio-renal protective therapies for people with chronic kidney disease who do not have diabetes or heart failure?

Evidence is limited concerning the implementation of cardio-renal protective therapies in patients with CKD without diabetes or heart failure, typically constrained by safety concerns, costs, and systemic inefficiencies in primary care.